Daniel E. Geffken - Oct 8, 2021 Form 4 Insider Report for PHOENIX BIOTECH ACQUISITION CORP. (PBAX)

Role
Chief Financial Officer
Signature
/s/ Chris Ehrlich, as attorney-in-fact
Stock symbol
PBAX
Transactions as of
Oct 8, 2021
Transactions value $
$0
Form type
4
Date filed
10/12/2021, 07:35 PM
Previous filing
Oct 5, 2021
Next filing
Dec 1, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBAX Class B Common Stock Other +30K 30K Oct 8, 2021 Class A Common Stock 30K By Phoenix Biotech Sponsor, LLC F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date.
F2 Allocated to the reporting person as a member of Phoenix Biotech Sponsor, LLC.
F3 The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for any other purpose.